Dr. Myra M Mizokami MD Pediatric Hematologist-Oncologist

Dr. Myra Mizokami is a pediatric hematologist-oncologist in Oakland, California. She received her medical degree from Keck School of Medicine of USC and has been in practice for 8 years.

Are you Dr. Myra Mizokami? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Pediatric Hematologist-Oncologist: General Pediatric Hematology & Oncology

Education & Medical Training

Children's Hospital - Oakland
Residency, Pediatrics, 2002 - 2005

Children's Hospital - Oakland
Fellowship, Pediatric Hematology/Oncology, 2006 - 2008

Keck School of Medicine of USC
Class of 2002

Certifications & Licensure

American Board of Pediatrics
Certified in Pediatrics

American Board of Pediatrics
Certified in Pediatric Hematology-Oncology

CA State Medical License
Active through 2013

Publications & Presentations

Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies.
Mizokami, M.M., Hu, P., Khawli, L.A., Li, J., Epstein, A.L.

Identification of a protein fragment of interleukin 2 responsible for vasopermeability.
Epstein, A.L., Mizokami, M.M., Li, J., Hu, P., Khawli, L.A.

Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotin.
Khawli, L.A., Mizokami, M.M., Sharifi, J., Hu, P., Epstein, A.L.

See all 5 publications
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.